Fair Value Calculator Fair Value Calculator
EN DE

HBSL (HBSL) Fair Value & Analysis

Financial Services · Market cap ₹368M

H HBSL HBSL · NSE
Price₹52.74
Fair Value₹13.35
Upside-74.7%
Quality47/100
Watch HBSL for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹7.56 – ₹18.07

Fair value as of: Jul 3, 2026

From 3 valuation models · updated today

Share price −1.9% over the past month.

Price vs Fair Value (12 months)

₹100.42 ₹42.63 Fair Value ₹13.35 Jul 2025 Jul 2026

12‑month range ₹42.63 – ₹100.42 · fair‑value band ₹7.56 – ₹18.07 · the ₹52.74 price screens above the ₹13.35 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HBSL (HBSL) currently trades at ₹52.74, while our model-based Fair Value estimate is ₹13.35 — implying the stock looks roughly 74.7% overvalued today. We read business quality at 47/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at ₹25.8M. Revenue declined 79.6% year over year. It earns a return on equity of -12.8%. Net debt stands at ₹94.3M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹25.8M
Revenue growth (YoY) -79.6%
Return on equity -12.8%
Free cash flow −₹71.7M FY2026
Operating margin -301%
EPS (TTM) ₹-15.16
More key figures
EPS growth (YoY) +15.7%
Net debt ₹94.3M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HBSL reported revenue of −₹58.6M in FY2026 versus ₹69.0M in FY2022. Reported net income was −₹108M in FY2026.

Revenue
FY22 ₹69.0M
FY23 ₹55.4M
FY24 ₹444M
FY25 ₹84.7M
FY26 −₹58.6M
Net income
FY22 ₹152M
FY23 −₹20.1M
FY24 ₹375M
FY25 −₹120M
FY26 −₹108M

Is HBSL fairly valued? → Check now

Similar stocks

6 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Huatai Securities Co HTSC $0.2700 $0.0500 -81%
Morgan Stanley, a financial holding company, MS $214.98 $138.97 -35%
The Goldman Sachs Group GS $1,077 $593.07 -45%
CITIC Securities Company 600030 ¥25.67 ¥51.34 +100%
6030 6030 HK$27.26 HK$30.74 +13%
Mirae Asset Securities Co 006800 46,100 KRW 36,828 KRW -20%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is HBSL (HBSL) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹13.35 versus a price of ₹52.74 — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HBSL?
Our model-based fair value for HBSL is ₹13.35 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹52.74.
What is the quality score of HBSL?
HBSL has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of HBSL (HBSL)?
HBSL reported trailing-twelve-month revenue of about ₹25.8M (latest available figure, as of Jul 3, 2026).
What is the net profit margin of HBSL?
The net profit margin of HBSL is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.